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Article / Clinical Case Report
ABSTRACT
Primary splenic angiosarcoma (PSA) is a rare neoplasm of vascular origin associated with aggressive behavior and 
poor prognosis. The clinical presentation is usually non-specific and is mostly characterized by a wasting disease with 
anemia and splenomegaly, mimicking a wide range of entities. The authors present the case of an 80-year-old woman 
with cardiovascular comorbidities with a 6-month history of weight loss, fatigue, weakness, pallor, and abdominal 
pain. The physical examination showed massive splenomegaly and pallor. After a thorough evaluation that ruled out 
lymphoproliferative diseases, the working diagnosis was a myelodysplastic disorder. A few days after discharge, she 
returned to the emergency room with severe abdominal pain, worsening fatigue, and a remarkable pallor. Point-of-care 
ultrasound showed free intraperitoneal fluid. Spleen rupture was confirmed by abdominal computed tomography (CT) 
scan, and an emergency laparotomy with splenectomy was performed. The postoperative period was uneventful, and 
the patient recovered in a few days. The histopathology confirmed the diagnosis of PSA and the patient was referred 
to an oncological center. Two months later staging CT demonstrated liver and peritoneal metastases, and despite the 
chemotherapy she died 6 months after the diagnosis. 
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INTRODUCTION
Primary splenic angiosarcoma (PSA) is a malignant 
mesenchymal-derived elongated endothelial cell 
originating from the splenic sinusoidal endothelial cells.1 
PSA is a rapidly proliferating, highly infiltrating, and 
widely spreading neoplasm, despite its insidious, often 
asymptomatic, presentation.2 Clinical manifestations 
are non-specific, including fatigue, abdominal pain, 
anorexia, weight loss, and anemia. Similarly, the imaging 
studies are often non-specific; however, splenomegaly 
with enlargement greater than 12 cm length, in the 
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presence of a complex mass and hypervascular tumors 
may be found.3 The diagnosis is challenging and is 
often made only after splenectomy. More than 300 PSA 
cases have been described.4 Azevedo et al.5 reported 
the case of a 57-year-old woman previously treated 
for breast ductal carcinoma, and as far as we know, 
to date, our case was the first case report of PSA with 
spontaneous rupture in a patient in Brazil.
Our report is to remind physicians to include 
this entity among the differential diagnoses for 
splenomegaly. We also would like to highlight the 
first reported case of PSA with spontaneous rupture 
in Brazil, based on a literature review in the PubMed, 
Scielo, Lilacs, Web of Science databases, over an 
unlimited period, using the keyword “Primary Splenic 
Angiosarcoma
CASE REPORT
An 80-year-old woman was admitted with a 
6-month history of progressive abdominal pain, 
weight loss, fatigue, and pallor. Her past medical 
history included hypertension and atherosclerotic 
cardiovascular disease. The physical evaluation 
was generally unremarkable except for massive 
splenomegaly and pallor. The spleen edge was 
palpable 10 cm below the left costal margin, firm, and 
painless. There was no palpable lymphadenopathy. 
The laboratory work-up showed anemia (hemoglobin 
was 8.9 g/dL; reference range [RR]: 12.3–15.3 g/dL) 
with mild microcytosis (MCV = 79.3 fL/red cell) and 
1.36% of reticulocytes. The white blood cell and 
platelet counts were within the reference range 
and distribution. Renal and liver function test results 
were in the reference range with a ferritin level 
of 206 ng/mL (RR: 13–150 ng/mL) and transferrin 
saturation of 10% (RR: 20%–50%). The folic acid 
and vitamin B12 determinations were unremarkable. 
An abdominal computed tomography (CT) scan 
revealed a 24 × 11 × 18 cm diffusely heterogeneous 
spleen with hypovascular areas with a volume 
of 2470 mL (RR: 107.2–314.5 mL). The liver was 
unremarkable, and no evidence of venous thrombosis 
or abdominal lymphadenopathy was found (Figure 1).
Chest CT scan suggested cardiomegaly and 
coronary atherosclerotic disease. Upper digestive 
endoscopic evaluation revealed a small gastric polyp, 
which was revealed to be a foveolar polyp. A bone 
marrow biopsy disclosed an increased population 
of the three cellular lineages for the patient’s age; 
approximately 60% cellularity with increased 
granulocytic precursors, suggestive of retarded 
maturation, including 1% of CD34 immature cells. 
There was no morphological evidence of lymphoma 
and no reticulin fibrosis. The patient was discharged 
and referred to an outpatient clinic follow-up with 
the working diagnosis of splenomegaly secondary to 
myelodysplastic syndrome. One week later, the patient 
returned to the emergency room complaining of acutely 
worsening abdominal pain. There was no history 
of trauma before the onset of symptoms. Physical 
examination showed hemodynamic instability (mean 
arterial pressure of 57 mmHg, pulse rate of 86 bpm), 
with marked pallor, and diffuse abdominal tenderness. 
Laboratory studies revealed a hemoglobin value of 
5.7 g/dL with mild microcytosis (MCV = 79.1 fL/red cell) 
and leukocytosis. The platelet count and renal and 
liver functions remained in reference ranges. Serologic 
studies for HIV, hepatitis B, and C, and syphilis were 
negative. After clinical stabilization and packed red 
blood cell transfusion, a point-of-care ultrasound 
revealed free intraperitoneal fluid. The abdominal CT 
scan confirmed mild hemoperitoneum attributable to 
spleen rupture and an emergency laparotomy with 
splenectomy was performed. The postoperative period 
was uneventful, and the patient was discharged after 
6 days of hospitalization. Two months after discharge, 
the patient was re-evaluated and the CT images 
showed metastases in the liver and peritoneum.
PATHOLOGICAL REPORT
The spleen was enlarged, weighing 1200g 
(RR: 112g) and measuring 18.0 × 13.0 × 6.5 cm. 
The splenic capsule had multiple disrupted areas 
with f ibr in deposit ion. Macroscopic sect ions 
showed multiple ill-defined nodular areas; the larger 
ones were white and firm and smaller ones were 
blue-red and spongy (Figure 2). On microscopy, the 
spleen parenchyma was replaced by anastomosing, 
irregularly ectatic vascular channels lined by plump 
mildly atypical lining cells. Intercalated solid fusiform 
areas consisted of spindle cell fascicles showing 
moderate nuclear atypia, with frequent mitotic 
figures. These closely packed vascular channels 
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Figure 1. Abdominal CT. A and B – axial plane; C – coronal plane; D – sagittal plane; B, C and D – after contrast 
enhancement showing large, expansive, and hyper vascularized mass within the spleen with wash-out, displacing 
adjacent structures. No lymphadenomegaly was observed.
Figure 2. Gross view of the spleen, showing ill-defined, white nodular areas with firm consistency intercalated with 
smaller blue-red, spongy nodules.
were filled with red blood cells. Small eosinophilic 
globules identified in the cytoplasm of the spindle 
cells were highlighted by periodic-acid Schiff (PAS) 
reagent (Figures 3 and 4).
Immunohistochemistry demonstrated diffuse 
positivity for CD31 and FLI-1 in both the spongy and the 
solid fusiform areas. However, CD34 was reactive only 
in the fusiform areas. D2-40 was not demonstrated. 
There was no positive expression for CD8, CD68, 
lysozyme or CD21 on the tumor cells. The Ki-67 index 
was increased (about 50%) in the spindle cell areas 
when compared to the spongy areas (about 10%) 
(Figures 5 and 6). Despite the morphological aspects 
of littoral cell hemangioma, the presence of atypia, 
the high index of the Ki67 and the immunophenotype 
were consistent with angiosarcoma.
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Figure 3. Photomicrographs of the spleen. A – Solid area showing spindle cells fascicles representing closed packed 
vascular spaces intercalated with anastomosing vascular channels (H&E, 100X); B – Spongy area showing irregular 
anastomosing vascular channels lined by plump cells (H&E, 100X); C – Transition between a solid area with spindle 
cells showing mild to moderate nuclear atypia and a spongy area (H&E, 200X); D – Irregular anastomosing vascular 
channels lined by plump cells with mild nuclear atypia (H&E, 200X).
Figure 4. Photomicrographs of the tumor highlighting the atypical features. A – Plump cells with mild nuclear atypia 
lining the spongy areas. Note the intermediate nuclear sized and irregular nuclear contour (H&E, 400X); B – Fusocellular 
areas showing frequent mitosis (arrows; H&E, 400X); C – Enlarged and irregular nuclei in the spindle cell areas (arrow; 
H&E, 400X); D – Presence of small eosinophilic globules in the cytoplasm of spindle cells (H&E, 400X).
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Figure 5. Photomicrographs of the spleen (all pictures 200X) – Immunohistochemical panel. A – CD68 was negative 
in the cells lining the vascular channels. Note the presence of histiocytes internal positive control; B – Strong and 
diffuse CD31 positivity in both spindle cells and plump cells lining the anastomosing channels; C – CD34 was 
positive in the solid area with spindle cells; D – Strong and diffuse FLI-1 positivity in both spindle cells and plump 
cells lining the anastomosing channels.
Figure 6. Photomicrographs of immunohistochemistry marker Ki-67 showing the higher index in the spindle cell 
area (50%) than the spongy area (10%) (A and B – 400X). PAS staining highlights the eosinophilic intracytoplasmic 
globules, as well as some histiocytes (C – 600X).
DISCUSSION
Originally described by Theodor Langhans6 in 
1879, the PSA is one of the rarest human malignancies, 
with an estimated annual incidence of 0.14 to 0.25 per 
million people. PSA is the rarest type of angiosarcoma 
and accounts for 2.6% or less of all soft tissue 
angiosarcomas.2,7-9 Notwithstanding, PSA is the most 
frequent non-lymphoid primary neoplasm of the 
spleen.10 PSA is thought to arise from the splenic red 
pulp’s immature endothelial-type cells.11 This entity 
usually is highly aggressive with a metastatic rate 
ranging from 69% to 100%; metastases are mostly 
seen in the liver, lungs, lymph nodes, and bones.1,12 
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The dismal prognosis may reflect the indolent 
presentation with a relatively late-stage diagnosis. 
Benign splenic tumors, such as hemangiomas or 
hemangioendotheliomas, have been suggested 
as precursors to PSA.7,12,13 PSA has been reported 
in association with environmental or occupational 
exposure to carcinogens as ionizing radiation 
(e.g. thorium dioxide), arsenic, vinyl chloride, and 
chemotherapy for lymphoma, these causal relationships 
have not been unequivocally substantiated, and most 
cases occur without identifiable risk factors.4,14,15 PSA is 
generally a neoplasm of middle-aged and older people 
with the mean age at presentation of 50–60 years, but 
cases in young people and children also have been 
reported.7,16-19 A slight male predilection has been 
observed. Most clinical manifestations are variable 
and unspecific, such as fatigue, anorexia, weight loss, 
and abdominal pain. The laboratory work-up shows 
anemia, and eventually leukopenia or leukocytosis 
(more common), and thrombocytopenia. Serum lactate 
dehydrogenase (LDH) value is often elevated, and 
consumption coagulopathy has been reported.12,20 
Splenomegaly is present in 85% of cases and may be 
the single manifestation.1,12 In up to 30% of cases, the 
first presentation consists of an acute abdomen with 
uncontrolled hemorrhagic shock due to spontaneous 
splenic rupture.7,12
Imaging diagnosis of PSA remains challenging 
because of the overlap with other vascular splenic 
tumors. The imaging features vary according to 
the examination technique modality; however, 
splenomegaly is virtually always evident. Ultrasound 
depicts a heterogeneous echotexture complex solid 
mass with an area of necrosis, and hemorrhage. 
Cystic formations within the mass are occasionally 
seen with associated increased vascularity on 
Doppler examination. On the CT, solitary or multiple 
nodular masses that exhibit heterogeneous contrast 
enhancement are present. Necrosis and hemorrhagic 
foci likely contribute to the heterogeneity of the images, 
and hemoperitoneum is generally recognized in cases 
of spontaneous rupture. No particular calcification 
pattern is described. The magnetic resonance imaging 
shows areas of increased and decreased signal intensity 
in both T1- and T2-weighed sequences, reflecting a 
solid tumor with areas of necrosis.12,21,22
Pathologic findings include splenomegaly with a 
mean splenic weight of 1073g (RR: 112g).12 The tumor 
descriptions range from firm and well-circumscribed 
to poorly-limited spongy tumor, with hemorrhagic, 
necrotic, or nodular lesions, and cystic spaces. 
Scattered tumor areas within the spleen can be seen 
but eventually the neoplastic process replaces the entire 
splenic parenchyma.6,12 Our patient is an elderly woman 
with clinical and radiological features consistent with 
the reported characteristics of PSA, and no history of 
risk factor exposure was identified. Most often PSA is 
both nodular with relatively homogeneous features 
associated with poorly circumscribed infiltrative 
tumor. A vasoformative component consistent with 
disorganized anastomosing vascular channels lined 
by atypical endothelial cells with bizarre giant cells are 
often seen. These giant cells were not found in our 
case. In addition, intracytoplasmic hyaline globules 
can be identified with H&E staining; the globules 
are highlighted with the PAS reaction. Eosinophilic 
nuclear bodies in the atypical cells are sometimes 
present. Vascular spaces may present as “slit-like,” 
“honeycomb-like,” or capillary-like patterns. A solid 
sarcomatous pattern interfaces with the vasoformative 
regions. Sheets of malignant epithelioid cells with 
round to irregular nuclei with vesicular nuclear 
chromatin may be present. The histological appearance 
and grade do not directly correlate with the outcome, 
although the mitotic index and the tumor size are 
considered prognostic factors.18 Hemophagocytosis, 
hemosiderin, extramedullary hematopoiesis, amyloid, 
and calcification may be found in variable degrees 
within the tumoral mass.12 The immunohistochemical 
profile is characterized by the presence of endothelial 
markers such as CD31, CD34, FVIII-RA, VEGFR3, and 
FLI 1. At least two of these markers are required for 
the diagnosis. Although the presence of histiocytic 
markers has been considered a clue for the diagnosis 
of PSA in some reports, they are not ubiquitous. 
Neuhauser et al.12 reported that 89% of cases (24/27) 
exhibited positivity to one or both histiocytic markers 
(56% were positive for CD68, and 56% for lysozyme). 
Therefore, “the lack of histiocytic markers may not 
dissuade from diagnosis of angiosarcoma, if atypia and 
increased mitotic activity, shared with angiosarcomas, 
are present” (Dr. Neuhauser personal communication). 
The histomorphological features of the index case are 
those of PSA, confirmed by the immunohistochemical 
markers of vascular origin. The presence of atypia and 
the high Ki67 index, plus the absence of histiocytic 
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markers in tumor cells helped rule out the diagnosis 
of littoral cell angioma, which is the main differential. 
In the series of Falk et al.7; only 1 case in 23 presented 
positivity for CD68. These markers are not found 
in angiosarcoma of sites other than the spleen. 
The mitotic index by Ki 67 usually varies between 
5% and 10%. In the case reported by Coppola et al.,15 
the positivity for CD 68 was interpreted as possible 
littoral cell origin of the neoplastic cells. Littoral cell 
angiomas are splenic vascular tumors that mimic the 
findings of hypovascular angiosarcomas but generally 
do not diffusely involve the spleen and do not show 
atypia. The differential diagnosis of splenomegaly 
with a complex mass includes hemangiomas, littoral 
cell angioma, lymphangioma, hemangiopericytoma, 
lymphoid-origin neoplasia, and metastatic disease. 
In the setting of metastatic disease, ovarian carcinoma 
is among the more common primary tumors that 
metastasizes to the spleen and should be considered 
in the differential diagnosis although the histologic 
features are not those of PSA.23 The presence of 
concomitant malignant tumors in patients with PSA—
markedly breast cancer, lymphoma, colon cancer, skin 
cancer, and renal cell carcinoma—has been reported.24
In a review 4 of 110 Chinese PSA cases, nearly 
70% had metastases by the time of diagnosis, and 
60% presented as splenic rupture. Moreover, some 
series reported a rate of 100% of metastasis to liver, 
bone, and bone marrow, as well as a poor prognosis 
with a survival rate of 20% in 6 months.3,4,7,12,14-17 
Splenic biopsy is generally contraindicated because 
of the high risk of inducing rupture and may not 
render the diagnosis. Reliable diagnosis is made 
after splenectomy and histological study,25 although 
diagnosis with fine-needle aspiration cytology has 
been reported.26
The treatment of PSA is challenging.14 Splenectomy 
is the main treatment for PSA and ideally should 
be performed before splenic rupture, with direct 
impact on the survival time. Even though there is 
no standard chemotherapy regimen, epirubicin and 
ifosfamide,7 paclitaxel,27 and the same chemotherapy 
regimen as used for follicular lymphoma28 have been 
reported as chemotherapy options. There is one case 
of high-dose chemotherapy followed by auto-PBSCT 
(peripheral blood stem cell transplantation), in which 
the patient had 5 years of progression-free survival, 
but eventually died after recurrence of disease.29 
Other drugs are bevacizumab30 and immunotherapy 
with rIL-2.31,32 The first one, which is a recombinant 
humanized antibody against the vascular endothelial 
growth factor, has been used in some case reports for 
angiosarcoma from other sites.
At the time of our patient’s splenectomy, the 
abdominal cavity’ did not show evidence of metastases, 
and neither did the imaging exams. However, in 
keeping with the known aggressive behavior of PSA, 
she presented liver and peritoneal metastases two 
months after surgery. Clinical deterioration (Karnofsky 
Performance Status 70% and PS-ECOG 2), and daily 
febrile reactions with no evidence of infection, as well 
as evidence of PSA at other sites,33 prompted treatment 
with paclitaxel. We also started non-selective β-AR 
antagonists because of her cardiovascular disease, as 
we considered that it may have a role in controlling 
angiosarcoma, based on previous data.34 However, our 
patient died of hepatic failure due to massive hepatic 
infiltration and sepsis. Although no metastases were 
found at the time of diagnosis and on the laparotomy, 
she died in 6 months after the diagnosis.
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